Shefali Lutra

Shefali Lutra, a healthcare and health policy reporter for Kaiser Health News, dives into the contentious issue of PrEP drug pricing. She discusses how high costs affect access for at-risk individuals, particularly in the LGBTQ community. The conversation sheds light on Gilead's monopolistic practices and the ongoing struggles faced by the uninsured and underinsured. Lutra also critiques the U.S. drug pricing landscape and legislative efforts that aim to make essential medications more accessible while addressing the balance between pharmaceutical profits and public health.